Vyne Therapeutics Inc (VYNE) is a biotechnology company listed on NASDAQ.
Latest reported VYNE revenue for 2025-12-31 was $570.0K. Net income was -$26.5M. Revenue was up 13.8% from 2024-12-31 to 2025-12-31. VYNE currently screens at market cap $21.1M.
Use this VYNE page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the VYNE quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the VYNE SEC filings page. Lician reads the product cache first so this HTML stays unique to Vyne Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full VYNE income, balance, and cash tables.